Doxazosin for benign prostatic obstruction

Timothy J. Wilt; Roderick Macdonald; Indy Rutks

doi:10.1002/14651858.CD003714.pub2

Doxazosin for benign prostatic obstruction

Timothy J. Wilt, Roderick Macdonald, Indy Rutks

Medicine - Veteran's Administration Medical Center

Research output: Contribution to journal › Article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: Our goal is to conduct a systematic review and quantitative meta-analysis of the existing evidence from randomized controlled trials to determine the efficacy and safety of the alpha-blocker doxazosin (Cardura, Pfizer Pharmaceuticals) in men with lower urinary tract symptoms compatible with BPO.

Original language	English (US)
Article number	CD003714
Journal	Cochrane Database of Systematic Reviews
Volume	2013
Issue number	6
DOIs	https://doi.org/10.1002/14651858.CD003714.pub2
State	Published - Jun 29 2013

Publisher link

10.1002/14651858.CD003714.pub2

Find It

Find It at U of M Libraries

Cite this

@article{18ca2f9f24994a8784b25a8ac742c131,

title = "Doxazosin for benign prostatic obstruction",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: Our goal is to conduct a systematic review and quantitative meta-analysis of the existing evidence from randomized controlled trials to determine the efficacy and safety of the alpha-blocker doxazosin (Cardura, Pfizer Pharmaceuticals) in men with lower urinary tract symptoms compatible with BPO.",

author = "Wilt, {Timothy J.} and Roderick Macdonald and Indy Rutks",

year = "2013",

month = jun,

day = "29",

doi = "10.1002/14651858.CD003714.pub2",

language = "English (US)",

volume = "2013",

journal = "The Cochrane database of systematic reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - Doxazosin for benign prostatic obstruction

AU - Wilt, Timothy J.

AU - Macdonald, Roderick

AU - Rutks, Indy

PY - 2013/6/29

Y1 - 2013/6/29

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: Our goal is to conduct a systematic review and quantitative meta-analysis of the existing evidence from randomized controlled trials to determine the efficacy and safety of the alpha-blocker doxazosin (Cardura, Pfizer Pharmaceuticals) in men with lower urinary tract symptoms compatible with BPO.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: Our goal is to conduct a systematic review and quantitative meta-analysis of the existing evidence from randomized controlled trials to determine the efficacy and safety of the alpha-blocker doxazosin (Cardura, Pfizer Pharmaceuticals) in men with lower urinary tract symptoms compatible with BPO.

UR - http://www.scopus.com/inward/record.url?scp=85048508481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048508481&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD003714.pub2

DO - 10.1002/14651858.CD003714.pub2

M3 - Article

AN - SCOPUS:85048508481

VL - 2013

JO - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

SN - 1361-6137

IS - 6

M1 - CD003714

ER -

Doxazosin for benign prostatic obstruction

Abstract

Publisher link

Find It

Other files and links

Fingerprint

Cite this